[Study of apoptosis manifestations in streptozotocin diabetes mellitus]

Fiziolohichnyi Zhurnal (Kiev, Ukraine : 1994)
|December 11, 2003
PubMed

Insights

Type I diabetes mellitus increases apoptosis in rat pancreas, brain, and myocardium. Apoptotic cells, identified by DNA damage and nuclear changes, play a key role in diabetes pathogenesis.

Area of Science:

  • Cell Biology
  • Pathology
  • Biochemistry

Context:

  • Apoptosis, or programmed cell death, is a fundamental biological process implicated in various physiological and pathological conditions.
  • Type I diabetes mellitus is a complex metabolic disorder characterized by hyperglycemia and long-term complications affecting multiple organs.
  • Understanding the role of apoptosis in diabetes pathogenesis is crucial for developing targeted therapeutic strategies.

Purpose:

  • To investigate the presence and quantify apoptotic cells in the pancreas, brain, and myocardium of rats with experimentally induced Type I diabetes mellitus.
  • To evaluate the efficacy of the TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) method and image analysis in detecting and differentiating apoptotic cells.
  • To elucidate the contribution of apoptosis to the pathological changes observed in key organs during diabetes.

Summary:

  • Apoptotic cells were detected in the pancreas, brain, and myocardium of healthy rats, with their detectability influenced by tissue fixation methods.
  • The TUNEL assay, combined with methyl green counterstaining and automated image analysis based on nuclear optical density, effectively identified apoptotic cells.
  • Development of Type I diabetes mellitus led to a significant increase in apoptotic cell numbers across all studied tissues, highlighting apoptosis's critical role in the disease.

Impact:

  • This study provides quantitative evidence for the increased apoptosis in vital organs during Type I diabetes, underscoring its pathological significance.
  • The findings suggest that targeting apoptosis pathways could be a potential therapeutic avenue for managing diabetes and its associated organ damage.
  • The validated methodology offers a reliable approach for future research investigating apoptosis in diabetes and other diseases.

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...